We are live on
!
Find out more
West Pharmaceutical
776 hedge funds and large institutions have $22.4B invested in West Pharmaceutical in 2024 Q2 according to their latest regulatory filings, with 88 funds opening new positions, 278 increasing their positions, 293 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
43% more call options, than puts
Call options by funds: $148M | Put options by funds: $104M
13% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 78
0.15% more ownership
Funds ownership: 93.62% → 93.77% (+0.15%)
0% less funds holding
Funds holding: 778 → 776 (-2)
5% less repeat investments, than reductions
Existing positions increased: 278 | Existing positions reduced: 293
17% less capital invested
Capital invested by funds: $27B → $22.4B (-$4.6B)
67% less funds holding in top 10
Funds holding in top 10: 9 → 3 (-6)
Holders
776
Holders Change
-2
Holders Change %
-0.26%
% of All Funds
11.21%
Holding in Top 10
3
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-66.67%
% of All Funds
0.04%
New
88
Increased
278
Reduced
293
Closed
78
Calls
$148M
Puts
$104M
Net Calls
+$44.7M
Net Calls Change
+$86.7M
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$566M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$150M |
| 3 |
LGF
LGT Group Foundation
Vaduz,
Liechtenstein
|
+$73.9M |
| 4 |
LIP
Liontrust Investment Partners
London,
United Kingdom
|
+$68.9M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$63.8M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$276M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$136M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$120M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$116M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$65.9M |
